ED Patient's Perceptions and Acceptability Toward a Novel POC HCV Viral Load Testing

NANot yet recruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

November 30, 2025

Primary Completion Date

November 30, 2027

Study Completion Date

November 30, 2027

Conditions
Hepatitis C
Interventions
DIAGNOSTIC_TEST

Xpert HCV Viral Load Finger-stick Point-of-Care test (Cepheid)

The investigators will randomly assign eligible and consented patients to either to HCV POC VL Group or Reference Group. All participants will take a short survey regarding HCV care and treatment. As part of the investigators' ED HCV Screening and Linkage to Care Program, all participants will receive the standard-of-care clinical laboratory-based HCV RNA viral load testing via whole blood (i.e. patient will receive blood drawn). This standard-of-care HCV viral load testing result will be provided to participant when it is available (usually 1-2 days later). Participants in the HCV POC VL Group will receive the novel POC HCV RNA viral load testing and the result of the novel test will be disclosed to the patients approximately within 1 to 1½ hours of the testing.

Trial Locations (1)

21287

Johns Hopkins University, Baltimore

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Cepheid

INDUSTRY

lead

Johns Hopkins University

OTHER

NCT03767231 - ED Patient's Perceptions and Acceptability Toward a Novel POC HCV Viral Load Testing | Biotech Hunter | Biotech Hunter